Top

Published in:

01-04-2018 | Original Article

Fractional anisotropy of white matter, disability and blood iron parameters in multiple sclerosis

Authors: Estelle Herbert, Penelope Engel-Hills, Coenraad Hattingh, Jean-Paul Fouche, Martin Kidd, Christine Lochner, Maritha J. Kotze, Susan J. van Rensburg

Published in: Metabolic Brain Disease | Issue 2/2018

Abstract

Multiple sclerosis (MS) is a disorder related to myelin damage, which can be investigated by neuroimaging techniques such as fractional anisotropy (FA), a measure of microstructural white matter properties. The objectives of this study were to investigate (1) the relationship between FA and disability using an extremes of outcome approach, and (2) whether blood iron parameters were associated with FA and/or disability. Patients diagnosed with MS (n = 107; 14 males and 93 females) had iron parameter tests and disability determinations using the Expanded Disability Status Scale (EDSS). FA was recorded in 48 white matter tracts in 11 of the female patients with MS and 12 female controls. Results: In patients with high disability scores the mean FA was significantly lower (0.34 ± 0.067) than in the control group (0.45 ± 0.036; p = 0.04), while patients with low disability had mean FA values (0.44 ± 0.014) similar to controls (p = 0.5). Positive associations were found between FA and the iron parameters serum iron, ferritin and percentage transferrin saturation (%Tfsat) in all the white matter tracts. For % Tfsat, the associations were highly significant in 14 tracts (p < 0.01; r-values 0.74–0.84) and p < 0.001 (r = 0.83) in the superior fronto occipital fasciculus (LH). In the whole patient group a trend was found towards an inverse association between the EDSS and the %Tfsat (r = −0.26, p = 0.05) after excluding male gender and smoking as confounders, suggesting reduced disability in the presence of higher blood iron parameters. Additionally, significant inverse associations between disease duration and haemoglobin (p = 0.04) as well as %Tfsat (p = 0.02) suggested that patients with MS may experience a decrease in blood iron concentrations over time.

Available only for authorised users

Anderson G, Rodriguez M (2015) Multiple sclerosis: the role of melatonin and N-acetylserotonin. Mult Scler Relat Disord 4:112–123. https://doi.org/10.1016/j.msard.2014.12.001 CrossRefPubMed

Anderson GJ, Frazer DM, McLaren GD (2009) Iron absorption and metabolism. Curr Opin Gastroenterol 25:129–135. https://doi.org/10.1097/MOG.0b013e32831ef1f7 CrossRefPubMed

Asaf A, Evan S, Anat A (2015) Injury to white matter tracts in relapsing–remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics. Neuro image Clin 8:261–266. https://doi.org/10.1016/j.nicl.2015.04.020

Ascherio A, Munger K, White R, Köchert K, Simon K, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Pleimes D, Radü EW, Sandbrink R, Kappos L, Pohl C (2014) Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 71:306. https://doi.org/10.1001/jamaneurol.2013.5993 CrossRefPubMedPubMedCentral

Barnett M, Prineas J (2004) Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 55:458–468. https://doi.org/10.1002/ana.20016 CrossRefPubMed

Bartzokis G (2011) Neuroglial pharmacology: white matter pathophysiologies and psychiatric treatments. Front Biosci 16:2695. https://doi.org/10.2741/3881 CrossRef

Bengtsson SL, Nagy Z, Skare S, Forsman L, Forssberg H, Ullén F (2005) Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci 8:1148–1150. https://doi.org/10.1038/nn1516 CrossRefPubMed

Bjartmar C, Wujek J, Trapp B (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165–171. https://doi.org/10.1016/S0022-510X(02)00069-2 CrossRefPubMed

Burgetova A, Seidl Z, Krasensky J, Horakova D, Vaneckova M (2010) Multiple sclerosis and the accumulation of iron in the Basal Ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry. Eur Neurol 63:136–143. https://doi.org/10.1159/000279305 CrossRefPubMed

Cesar B, Dwyer MG, Shucard JL, Polak P, Bergsland N, Benedict RH, Weinstock-Guttman B, Shucard DW, Zivadinov R (2015) Cognitive and white matter tract differences in MS and diffuse neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol 36:1874–1883. https://doi.org/10.3174/ajnr.A4354 CrossRefPubMed

Connor JR, Menzies SL (1996) Relationship of iron to oligondendrocytes and myelination. Glia 17:83–93. https://doi.org/10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7 CrossRefPubMed

Curtiss F (2007) Pharmacoeconomic Modeling of Drug Therapies for Multiple Sclerosis - Are We Building Houses on Sand? J Manag Care Pharm 13:287–289. https://doi.org/10.18553/jmcp.2007.13.3.287 PubMed

D’hooghe MB, Haentjens P, Nagels G, De Keyser J (2012) Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol 19:616–624. https://doi.org/10.1111/j.1468-1331.2011.03596.x CrossRefPubMed

Davis W, van Rensburg SJ, Cronje FJ, Whati L, Fisher LR, van der Merwe L, Geiger D, Hassan MS, Matsha T, Erasmus RT, Kotze MJ (2014) The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors. Metab Brain Dis 29:409–419. https://doi.org/10.1007/s11011-014-9486-7 PubMed

DeLuca GC, Ramagopalan SV, Herrera BM, Dyment DA, Lincoln MR, Montpetit A, Pugliatti M, Barnardo MC, Risch NJ, Sadovnick AD, Chao M (2007) An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. PNAS 104:20896–20901. https://doi.org/10.1073/pnas.0707731105 CrossRefPubMedPubMedCentral

Evans RW, Kong X, Hider RC (2012) Iron mobilization from transferrin by therapeutic iron chelating agents. Biochim Biophys Acta 1820:282–290. https://doi.org/10.1016/j.bbagen.2011.11.007 CrossRefPubMed

Faivre A, Robinet E, Guye M, Rousseau C, Maarouf A, Le Troter A, Zaaraoui W, Rico A, Crespy L, Soulier E, Confort-Gouny S, Pelletier J, Achard S, Ranjeva JP, Audoin B (2016) Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study. Mult Scler 22:1695–1708. https://doi.org/10.1177/1352458516628657 CrossRefPubMed

Hametner S, Wimmer I, Haider L, Pfeifenbring S, Brück W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74:848–861. https://doi.org/10.1002/ana.23974 CrossRefPubMedPubMedCentral

Hasan KM, Gupta RK, Santos RM, Wolinsky JS, Narayana PA (2005) Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients. J Magn Reson Imaging 21:735–743. https://doi.org/10.1002/jmri.20296 CrossRefPubMed

Herbert EP (2016) Magnetic resonance imaging and biochemical markers to assess disability in female subjects with multiple sclerosis. Dissertation, Cape Peninsula University of Technology

Jahanshad N, Kohannim O, Hibar DP, Stein JL, McMahon KL, de Zubicaray GI, Medland SE, Montgomery GW, Whitfield JB, Martin NG, Wright MJ, Toga AW, Thompson PM (2012) Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene. Proc Natl Acad Sci U S A 109:E851–E859. https://doi.org/10.1073/pnas.1105543109 CrossRefPubMedPubMedCentral

Karim ME, Gustafson P, Petkau J, Zhao Y, Shirani A, Kingwell E, Evans C, van der Kop M, Oger J, Tremlett H (2014) Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort. Am J Epidemiol 180:160–171. https://doi.org/10.1093/aje/kwu125 CrossRefPubMedPubMedCentral

Keser Z, Hasan KM, Mwangi B, Gabr RE, Steinberg JL, Wilken J, Wolinsky JS, Nelson FM (2017) Limbic Pathway Correlates of Cognitive Impairment in Multiple Sclerosis. J Neuroimaging 27:37–42. https://doi.org/10.1111/jon.12381 CrossRefPubMed

Khalil M, Langkammer C, Pichler A, Pinter D, Gattringer T, Bachmaier G, Ropele S, Fuchs S, Enzinger C, Fazekas F (2015) Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study. Neurology 84:2396–2402. https://doi.org/10.1212/WNL.0000000000001679 CrossRefPubMed

Koenig KA, Sakaie KE, Lowe MJ, Lin J, Stone L, Bermel RA, Beall EB, Rao SM, Trapp BD, Phillips MD (2013) High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment. Magn Reson Imaging 31:695–699. https://doi.org/10.1016/j.mri.2012.10.030 CrossRefPubMedPubMedCentral

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS). Neurology 33:1444–1452. https://doi.org/10.1212/WNL.33.11.1444 CrossRefPubMed

Lane DJ, Merlot AM, Huang MH, Bae DH, Jansson PJ, Sahni S, Kalinowski DS, Richardson DR (2015) Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease. Biochim Biophys Acta 1853:1130–1144. https://doi.org/10.1016/j.bbamcr.2015.01.021 CrossRefPubMed

Lassmann H (1998) Neuropathology in multiple sclerosis: new concepts. Mult Scler 4:93–98. https://doi.org/10.1177/135245859800400301 CrossRefPubMed

Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C (2012) Diffusion tensor imaging of white matter tract evolution over the lifespan. NeuroImage 60:340–352. https://doi.org/10.1016/j.neuroimage.2011 CrossRefPubMed

Limson J, Nyokong T, Daya S (1998) The interaction of melatonin and its precursors with aluminium, cadmium, copper, iron, lead, and zinc: an adsorptive voltammetric study. J Pineal Res 24:15–21. https://doi.org/10.1111/j.1600-079X.1998.tb00361.x CrossRefPubMed

Liu Y, Duan Y, He Y, Yu C, Wang J, Huang J, Ye J, Parizel PM, Li K, Shu N (2012) Whole brain white matter changes revealed by multiple diffusion metrics in multiple sclerosis: a TBSS study. Biomed Res Int 81:2826–2832. https://doi.org/10.1016/j.ejrad.2011.11.022

Llufriu S, Blanco Y, Martinez-Heras E, Casanova-Molla J, Gabilondo I, Sepulveda M, Falcon C, Berenguer J, Bargallo N, Villoslada P, Graus F (2012) Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study. PLoS One 7:e37167. https://doi.org/10.1371/journal.pone.0037167 CrossRefPubMedPubMedCentral

Lochner C, Fouché JP, du Plessis S, Spottiswoode B, Seedat S, Fineberg N, Chamberlain SR, Stein DJ (2012) Evidence for fractional anisotropy and mean diffusivity white matter abnormalities in the internal capsule and cingulum in patients with obsessive-compulsive disorder. J Psychiatry Neurosci 37:193–199. https://doi.org/10.1503/jpn.110059 CrossRefPubMedPubMedCentral

Lyksborg M, Siebner H, Sørensen P, Blinkenberg M, Parker G, Dogonowski GE, Larsen R, Dyrby TB (2014) Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity. PLoS One 9:e95540. https://doi.org/10.1371/journal.pone.0095540 CrossRefPubMedPubMedCentral

Manouchehrinia A, Tench C, Maxted J, Bibani R, Britton J, Constantinescu C (2013) Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 136:2298–2304. https://doi.org/10.1093/brain/awt139 CrossRefPubMedPubMedCentral

McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127. https://doi.org/10.1002/ana.1032 CrossRefPubMed

Moccia M, Lanzillo R, Palladino R, Maniscalco G, De Rosa A, Russo C, Massarelli M, Carotenuto A, Postiglione E, Caporale O, Triassi M, Brescia Morra V (2015) The Framingham cardiovascular risk score in multiple sclerosis. Eur J Neurol 22:1176–1183. https://doi.org/10.1111/ene.12720 CrossRefPubMed

Moremi K, van Rensburg SJ, Fisher LR, Davis W, Cronje FJ, Dashti M, Sefid J, Gamieldien J, Geiger D, Rensburg M, van Toorn R (2013) Association of an iron-related TMPRSS6 genetic variant c. 2207 C> T (rs855791) with functional iron deficiency and its effect on multiple sclerosis risk in the South African population. South African Journal of Psychiatry 19:120–121

Mori S, Wakana S, Nagae-Poetscher LM, van Zijl PC (2005) MRI atlas of human white matter. Elsevier, Amsterdam

Nelson MC, Isaacs F, Hassan MS, Kidd M, Cronje FJ, Van Rensburg SJ (2014) Prevalence of abnormal bloodflow patterns and effects of biochemistry and lifestyle factors on the major neck vessels in patients with Multiple Sclerosis in the Western Cape, South Africa. Medical Technology SA 28:28–33

Onu M, Roceanu A, Sboto-Frankenstein U, Bendic R, Tarta E, Preoteasa F, Bajenaru O (2012) Diffusion abnormality maps in demyelinating disease: correlations with clinical scores. Eur J Radiol 81:e386–e391. https://doi.org/10.1016/j.ejrad.2011.12.014 CrossRefPubMed

Phatlhane DV, Zemlin AE, Matsha TE, Hoffmann M, Naidoo N, Ichihara K, Smit F, Erasmus RT (2016) The iron status of a healthy South African adult population. Clin Chim Acta 460:240–245. https://doi.org/10.1016/j.cca.2016.06.019 CrossRefPubMed

Phillips O, Squitieri F, Sanchez-Castaneda C, Elifani F, Caltagirone C, Sabatini U, Di Paola M (2014) Deep white matter in Huntington's disease. PLoS One 9:e109676. https://doi.org/10.1371/journal.pone.0109676 CrossRefPubMedPubMedCentral

Pittock SJ, Rodriguez M (2008) Benign multiple sclerosis. Curr Top Microbiol Immunol 318:1–7. https://doi.org/10.1007/978-3-540-73677-6_1 PubMed

Rashid W, Hadjiprocopis A, Davies G, Griffin C, Chard D, Tiberio M, Altmann D, Wheeler-Kingshott C, Tozer D, Thompson A, Miller DH (2008) Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging. J Neurol 255:390–397. https://doi.org/10.1007/s00415-008-0678-0 CrossRefPubMed

Rensvold JW, Krautkramer KA, Dowell JA, Denu JM, Pagliarini DJ (2016) Iron Deprivation Induces Transcriptional Regulation of Mitochondrial Biogenesis. J Biol Chem 291:20827–20837. https://doi.org/10.1074/jbc.M116.727701 CrossRefPubMedPubMedCentral

Rodrigo L, Hernández-Lahoz C, Fuentes D, Alvarez N, López-Vázquez A, González S (2011) Prevalence of celiac disease in multiple sclerosis. BMC Neurol 11:31. https://doi.org/10.1186/1471-2377-11-31 CrossRefPubMedPubMedCentral

Rouault TA, Zhang DL, Jeong SY (2009) Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab Brain Dis 24:673–684. https://doi.org/10.1007/s11011-009-9169-y CrossRefPubMedPubMedCentral

Sbardella E, Tona F, Petsas N, Pantano P (2013) DTI measurements in multiple sclerosis: evaluation of brain damage and clinical implications. Mult Scler Int 2013:671730. https://doi.org/10.1155/2013/671730 PubMedPubMedCentral

Schmithorst VJ, Wilke M (2002) Differences in white matter architecture between musicians and non-musicians: a diffusion tensor imaging study. Neurosci Lett 321:57–60. https://doi.org/10.1016/S0304-3940(02)00054-X CrossRefPubMed

Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, Oger J, Gustafson P, Petkau J, Tremlett H (2012) Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA 308:247–256. https://doi.org/10.1001/jama.2012.7625 PubMed

Simpson IA, Ponnuru P, Klinger ME, Myers RL, Devraj K, Coe CL, Lubach GR, Carruthers A, Connor JR (2015) A novel model for brain iron uptake: introducing the concept of regulation. J Cereb Blood Flow Metab 35:48–57. https://doi.org/10.1038/jcbfm.2014.168 CrossRefPubMed

Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23(Suppl 1):S208–S219. https://doi.org/10.1016/j.neuroimage.2004.07.051 CrossRefPubMed

Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 31:1487–1505. https://doi.org/10.1016/j.neuroimage.2006.02.024 CrossRefPubMed

Swank RL, Dugan BB (1990) Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336:37–39CrossRefPubMed

Syka M, Keller J, Klempíř J, Rulseh AM, Roth J, Jech R, Vorisek I, Vymazal J (2015) Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of Huntington's disease patients. PLoS One 10:e0118907. https://doi.org/10.1371/journal.pone.0118907.eCollection2015 CrossRefPubMedPubMedCentral

Temel Ş, Kekliğkoğlu H, Vural G, Deniz O, Ercan K (2013) Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability. Neuroradiol J 26:3–17CrossRefPubMedPubMedCentral

Tettey P, Simpson S, Taylor B, van der Mei I (2014) Vascular comorbidities in the onset and progression of multiple sclerosis. J Neurol Sci 347:23–33. https://doi.org/10.1016/j.jns.2014.10.020 CrossRefPubMed

Thouvenot E, Orsini M, Daures J, Camu W (2014) Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis. Eur J Neurol 22:564–569. https://doi.org/10.1111/ene.12617 CrossRefPubMed

Todorich B, Zhang X, Connor JR (2011) H-ferritin is the major source of iron for oligodendrocytes. Glia 59:927–935. https://doi.org/10.1002/glia.21164 CrossRefPubMed

Trapp B, Bö L, Mörk S, Chang A (1999) Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 98:49–56. https://doi.org/10.1016/S0165-5728(99)00081-8 CrossRefPubMed

Tremlett H, Zhu F, Petkau J, Oger J, Zhao Y (2012) Natural, innate improvements in multiple sclerosis disability. Mult Scler 18:1412–1421. https://doi.org/10.1177/1352458512439119 CrossRefPubMed

Unger EL, Earley CJ, Thomsen LL, Jones BC, Allen RP (2013) Effects of IV iron isomaltoside-1000 treatment on regional brain iron status in an iron-deficient animal. Neuroscience 246:179–185. https://doi.org/10.1016/j.neuroscience.2013.04.049 CrossRefPubMed

van Rensburg SJ, van Toorn R (2010) The controversy of CCSVI and iron in multiple sclerosis: is ferritin the key? Neurology 75:1581–1582. https://doi.org/10.1212/WNL.0b013e3181fb44f0 CrossRefPubMed

van Rensburg S, Kotze M, van Toorn R (2012) The conundrum of iron in multiple sclerosis – time for an individualised approach. Metab Brain Dis 27:239–253. https://doi.org/10.1007/s11011-012-9290-1 CrossRefPubMedPubMedCentral

van Rensburg SJ, Davis W, Geiger D, Cronje FJ, Whati L, Kidd M, Kotze MJ (2015) Effects of diet, smoking and alcohol consumption on disability (EDSS) in people diagnosed with multiple sclerosis. S Afr J Psychiatr 21:121

van Rensburg SJ, van Toorn R, Moremi KE, Peeters AV, Oguniyi A, Kotze MJ (2016) Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient. Metab Brain Dis 31:197–204. https://doi.org/10.1007/s11011-015-9788-4 CrossRefPubMed

van Toorn R, Schoeman JF, Solomons R, Rensburg MA, van Rensburg SJ (2010) Iron status in children with recurrent episodes of tumefactive cerebral demyelination. J Child Neurol 25:1401–1407. https://doi.org/10.1177/0883073810366179 CrossRefPubMed

Vollmann H, Ragert P, Conde V, Villringer A, Classen J, Witte OW, Steele CJ (2014) Instrument specific use-dependent plasticity shapes the anatomical properties of the corpus callosum: a comparison between musicians and non-musicians. Front Behav Neurosci 8:245. https://doi.org/10.3389/fnbeh.2014.00245 CrossRefPubMedPubMedCentral

Weigel KJ, Lynch SG, LeVine SM (2014) Iron chelation and multiple sclerosis. ASN neuro 6:e00136. https://doi.org/10.1042/AN20130037 PubMedPubMedCentral

Weinberg ED (2009) Tobacco smoke iron: an initiator/promoter of multiple diseases. Biometals 22:207–210. https://doi.org/10.1007/s10534-008-9156-5 CrossRefPubMed

Williams R, Rohr AM, Wang WT, Choi IY, Lee P, Berman NE, Lynch SG, LeVine SM (2011) Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neurosci 12:59. https://doi.org/10.1186/1471-2202-12-59 CrossRefPubMedPubMedCentral

World Medical Association Declaration of Helsinki (2013) http://www.ub.edu/recerca/Bioetica/doc/Declaracio_Helsinki_2013.pdf

Worthington V, Killestein J, Eikelenboom MJ, Teunissen CE, Barkhof F, Polman CH, Uitdehaag BM, Petzold A (2010) Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology 75:1617–1622. https://doi.org/10.1212/WNL.0b013e3181fb449e CrossRefPubMed

Xu B, Chasteen ND (1991) Iron oxidation chemistry in ferritin. Increasing Fe/O2 stoichiometry during core formation. J Biol Chem 266:19965–19970PubMed

Xu X, Wang Q, Zhong J, Zhang M (2015) Iron deposition influences the measurement of water diffusion tensor in the human brain: a combined analysis of diffusion and iron-induced phase changes. Neuroradiology 57:1169–1178. https://doi.org/10.1007/s00234-015-1579-4 CrossRefPubMed

Zeman D, Adam P, Kalistová H, Sobek O, Kelbich P, Andel J, Andel M (2000) Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients. Acta Neurol Scand 101:89–94. https://doi.org/10.1034/j.1600-0404.2000.101002089.x CrossRefPubMed

Zhang T, Shirani A, Zhao Y, Karim ME, Gustafson P, Petkau J, Evans C, Kingwell E, van der Kop M, Zhu F, Oger J, Tremlett H, (2015) Beta-interferon exposure and onset of secondary progressive multiple sclerosis. European Journal Neurology 22(6):990–1000

Title: Fractional anisotropy of white matter, disability and blood iron parameters in multiple sclerosis
Authors: Estelle Herbert
Penelope Engel-Hills
Coenraad Hattingh
Jean-Paul Fouche
Martin Kidd
Christine Lochner
Maritha J. Kotze
Susan J. van Rensburg
Publication date: 01-04-2018
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 2/2018
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-017-0171-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Fractional anisotropy of white matter, disability and blood iron parameters in multiple sclerosis

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2018

Combined corticosterone treatment and chronic restraint stress lead to depression associated with early cognitive deficits in mice

Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat

Progress in neuroscience in Africa: editorial

Changes in the brain antioxidant profile after chronic vanadium administration in mice

Poly-N-methylated Aβ-Peptide C-Terminal fragments (MEPTIDES) reverse the deleterious effects of amyloid-β in rats

Differential epigenetic changes in the hippocampus and prefrontal cortex of female mice that had free access to cocaine